Brian Bertha is currently a consultant, adviser and board member, and has had a distinguished career as a businessman and innovator in technology and healthcare. He is currently on the National Board and Finance Committee of the American Diabetes Association. He was the Chief Operating Officer for Crescendo Bioscience in South San Francisco, CA, until it was acquired and integrated into Myriad Genetics; while there, he had responsibility for marketing, sales, manufacturing, information technology and business development. Prior to Crescendo Bioscience, he served in various senior leadership roles at McKesson U.S. Pharmaceutical, including Senior Vice President of Patient Relationship Solutions, Senior Vice President of Marketing, and Senior Vice President of Corporate Strategy and Business Development. As Senior Vice President of Marketing, his responsibilities included marketing strategy, product development and customer programs for all market segments, totaling more than $70 billion in annual sales. Prior to McKesson, Brian was part of the Senior Management Team at Baxter Bioscience in both the US and Europe; a consultant with Bain and Company in the US, Europe and Asia, and prior to that a practicing attorney in the San Francisco, CA, area working with venture firms and start-up companies.
Brian holds a JD from Harvard Law School in Cambridge, MA, an MBA from IMD in Lausanne, Switzerland, and a BA in International Relations from Brigham Young University in Provo, UT.